Our pilot study about cardiovascular abnormalities among adolescents and young adults with sickle cell disease is out. Read it here.
nature.com/articles/s41598-0…
Early metformin looked favorable in a secondary reanalysis of 526 gestational-diabetes pregnancies (win ratio 1.46), mainly through less insulin initiation. The original primary composite was neutral, so this is not a new definitive trial result. doi.org/10.1001/jamanetworko…
24
Abdul M. Ssekandi, MBChB, MSc., M.A.P.S retweeted
🔥 Two more Dissertations added to the master shelf.
🔥 Congratulations @kiconco_ritah on your PhD @MbararaUST
🔥 Congratulations Dr Mawanda Abdul Nasser upon completion in of MSc Physiology @Makerere
@JC_by_AMS @MirembeDr @SemitalaFred
Before adopting an innovation, hospitals should ask: Does it improve a patient outcome? Can our workflow deliver it reliably? What will we stop doing to fund it? A better biomarker, alert or device matters only when the care pathway converts it into benefit.
1
71
A paediatric obesity trial crossed a clinically important threshold: BMI fell 18.5% with tirzepatide vs rose 0.5% with placebo at 72 weeks. SURMOUNT-ADOLESCENTS randomized 160 participants; GI events were common. Long-term safety still matters. doi.org/10.1001/jama.2026.23…
30
Deprescribing improved only while stewardship was active. In 4,827 older inpatients across 6 hospitals, an EHR Drug Burden Index plus pharmacist support increased deprescribing by 5.3 points—then gains faded. Alerts alone are not implementation. doi.org/10.1001/jamainternme…
1
27
Culturally adapted Caring Contacts did not outperform enhanced usual care. Among 709 American Indian/Alaska Native adults with active suicidality, both groups improved; only 64% had 12-month data. Negative trials should refine community-led care. doi.org/10.1001/jamanetworko…
31
Robotic pancreatic surgery shortened median stay from 16 to 13 days—but cost more. PORTAL randomized 268 adults at 7 high-volume Chinese centres; recovery was non-inferior and operating time longer. Adoption must include expertise and total cost. doi.org/10.1136/bmj-2026-319…
38
Gene therapy cut mean annual bleeding from 13.9 to 0.5 in 11 adolescents with haemophilia B; mean factor IX activity reached 41.8 IU/dL at week 52. Promising, but this was a single-arm phase 1 trial: durability and rare harms remain unknown. doi.org/10.1038/s41591-026-0…
37
CT pulmonary angiography was avoided in 22% of patients with cancer and suspected PE. The 698-patient Hydra trial found YEARS non-inferior to CTPA-only management; 90-day failure was 1.8% vs 5.5%. Validation in African pathways is still needed. doi.org/10.1001/jama.2026.10…
46
More expensive did not mean more remission. In MAINRITSEG, 98 adults with EGPA spent 91.1 weeks in remission on rituximab vs 96.0 on azathioprine over 28 months; rituximab was not superior. Comparative trials should shape formularies. doi.org/10.1001/jama.2026.15…
1
130
In Jinja, 20 mg daily zinc reduced infections in 100 children under 5 with sickle cell anaemia: 305.7 vs 480.7 per 100 person-years over 6 months. ZIPS-2 is encouraging; one small, single-site trial should inform—not settle—policy. doi.org/10.1001/jama.2026.14…
52
AI support did not reduce 14-day treatment failure in Kenyan primary care. The pragmatic trial covered >9,000 consultations across 16 facilities and found no safety signal. For hospitals, the endpoint is patient outcomes—not polished documentation. doi.org/10.1038/s41591-026-0…
41
A useful test for any hospital innovation: What outcome should change, by how much, and by when? Then ask who owns implementation after the trial team leaves. Evidence on deprescribing, diagnostics and AI points to the same lesson: workflow determines whether tools become care.
59
An open-source AI “co-scientist” completed five biomedical analyses with externally testable findings. Roberts et al. report speed and auditability, not better patient outcomes. Hospitals need validation, governance and secure data before clinical use. doi.org/10.1038/s41591-026-0…
2
72
Five days of 40-Hz brain stimulation improved consciousness scores more than 4-Hz or sham in a randomized trial of prolonged disorders of consciousness. Promising neurophysiology; one short study cannot establish routine rehabilitation benefit.
sciencedirect.com/science/ar…
1
72
A blood test tracked advanced tau pathology—but is not a dementia screening test. In 728 participants, Brum et al.’s plasma eMTBR-tau assay aligned with neuropathology and tau-PET stages. Cross-sectional evidence needs clinical validation. doi.org/10.1001/jama.2026.25…
1
61
ctDNA surveillance doubled curative-intent treatment among colorectal cancer recurrences: 48.1% vs 23.6%. FIND randomized 584 eligible patients; recurrence itself was similar at 18.0% vs 18.6%. Survival benefit remains unproven. doi.org/10.1200/JCO-25-03009
52
Rituximab added no proteinuria or kidney-function benefit in IgA nephropathy. RITA randomized 106 adults already receiving optimized renin–angiotensin blockade; 12-month proteinuria was similar. A negative trial can prevent costly therapeutic drift.
ajkd.org/article/S0272-6386(…
59
Dapagliflozin modestly improved kidney-function trajectory after heart transplantation. DAPARHT randomized 430 recipients: 12-month eGFR change was 2.0 vs 0.3 mL/min/1.73m². Useful physiology, but the difference was small and follow-up short. doi.org/10.1161/CIRCULATIONA…
3
234
Post-hospital mobility did not improve with booklets, videos, staff training and ward posters. INTOMOB randomized 383 older adults across 12 Swiss ward clusters; the 30-day difference was 0.67 points. Low-intensity education alone may be insufficient. doi.org/10.1001/jamanetworko…
56





